Strainz

Strainz sells hemp-derived cannabinoid tinctures, softgels, topicals and pet formulas in strengths from 300 mg to 12,000 mg per bottle. Price points run mid-range to premium: human tinctures $49–$199, pet line $29–$89. All commerce is DTC through strainz.com with subscription discounts; no retail storefronts are operated. The company positions itself on pharmacist-formulated, USA-grown hemp processed in cGMP facilities and triple-lab tested for potency, pesticides and residual solvents. Its flagship “Ratio Series” pairs CBD with CBG, CBN or CBC in calibrated blends, while the “Strainz Pets” line is chicken-flavored and THC-free. Every product carries a scannable QR code linking to the exact COA batch report. Core buyers are 30-55-year-old wellness seekers managing stress, sleep or recovery without psychoactive cannabis; pet owners choose the brand for vet-advised, non-intoxicating support. Customers value transparent lab data, consistent minor-cannabinoid ratios and U.S. Hemp Authority certification. Strainz competes in the crowded online CBD wellness space against mass-market isolate brands and artisanal full-spectrum labels. It differentiates through high-milligram, minor-cannabinoid ratio SKUs, medical-advisory board credentials and a single-site supply chain that keeps premium formulations priced below boutique competitors while exceeding basic ISO safety standards.